Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHZ2200100	复方氨基酸(15)双肽(2)注射液	Injection	Chemical Drugs	License Renew	2022-04-15					view
JYHZ2200099	复方氨基酸(15)双肽(2)注射液	Injection	Chemical Drugs	License Renew	2022-04-15					view
JYHZ2200098	复方氨基酸(15)双肽(2)注射液	Injection	Chemical Drugs	License Renew	2022-04-15					view
JYHZ2200097	复方氨基酸(15)双肽(2)注射液	Injection	Chemical Drugs	License Renew	2022-04-15					view
JYHZ1700044	复方氨基酸(15)双肽(2)注射液	Injection	Chemical Drugs	License Renew	2017-08-03	费森尤斯卡比华瑞制药有限公司	Fresenius Kabi SSPC	Approval Completed-Pending Certificated	2018-02-01	view
JYHZ1700043	复方氨基酸(15)双肽(2)注射液	Injection	Chemical Drugs	License Renew	2017-08-03	费森尤斯卡比华瑞制药有限公司	Fresenius Kabi SSPC	Approval Completed-Pending Certificated		view
JYHZ1700042	复方氨基酸(15)双肽(2)注射液	Injection	Chemical Drugs	License Renew	2017-08-03	费森尤斯卡比华瑞制药有限公司	Fresenius Kabi SSPC	Approval Completed-Pending Certificated	2018-02-01	view
JYHZ1700041	复方氨基酸(15)双肽(2)注射液	Injection	Chemical Drugs	License Renew	2017-08-03	费森尤斯卡比华瑞制药有限公司	Fresenius Kabi SSPC	Approval Completed-Pending Certificated	2018-10-31	view
JYHF1800061	复方氨基酸(15)双肽(2)注射液	Injection	Chemical Drugs	Supplementary Application	2018-05-07	费森尤斯卡比华瑞制药有限公司	Fresenius Kabi SSPC	Certificate Issued	2018-06-07	view
JYHF1800060	复方氨基酸(15)双肽(2)注射液	Injection	Chemical Drugs	Supplementary Application	2018-05-07	费森尤斯卡比华瑞制药有限公司	Fresenius Kabi SSPC	Certificate Issued	2018-06-07	view
JYHB2200605	复方氨基酸(15)双肽(2)注射液	Injection	Chemical Drugs	Supplementary Application	2022-11-04		Fresenius Kabi Austria GmbH			view
JYHB2200604	复方氨基酸(15)双肽(2)注射液	Injection	Chemical Drugs	Supplementary Application	2022-11-04		Fresenius Kabi Austria GmbH			view
JYHB2200603	复方氨基酸(15)双肽(2)注射液	Injection	Chemical Drugs	Supplementary Application	2022-11-04		Fresenius Kabi Austria GmbH			view
JYHB2200602	复方氨基酸(15)双肽(2)注射液	Injection	Chemical Drugs	Supplementary Application	2022-11-04		Fresenius Kabi Austria GmbH			view
JYHB2100011	复方氨基酸(15)双肽(2)注射液	Injection	Chemical Drugs	Supplementary Application	2021-01-07	费森尤斯卡比华瑞制药有限公司	Fresenius Kabi SSPC	In Review	2021-01-06	view
JYHB2100010	复方氨基酸(15)双肽(2)注射液	Injection	Chemical Drugs	Supplementary Application	2021-01-07	费森尤斯卡比华瑞制药有限公司	Fresenius Kabi SSPC	In Review	2021-01-06	view
JYHB2100009	复方氨基酸(15)双肽(2)注射液	Injection	Chemical Drugs	Supplementary Application	2021-01-07	费森尤斯卡比华瑞制药有限公司	Fresenius Kabi SSPC	In Review	2021-01-06	view
JYHB2100008	复方氨基酸(15)双肽(2)注射液	Injection	Chemical Drugs	Supplementary Application	2021-01-07	费森尤斯卡比华瑞制药有限公司	Fresenius Kabi SSPC	In Review	2021-01-06	view
JYHB2002391	复方氨基酸(15)双肽(2)注射液	Injection	Chemical Drugs	Supplementary Application	2020-11-25	费森尤斯卡比华瑞制药有限公司	Fresenius Kabi SSPC	Filed	2020-12-03	view
JYHB2002390	复方氨基酸(15)双肽(2)注射液	Injection	Chemical Drugs	Supplementary Application	2020-11-25	费森尤斯卡比华瑞制药有限公司	Fresenius Kabi SSPC	Filed	2020-12-03	view